News

The iShares International Small-Cap Equity Factor ETF (ISCF) made its debut on 04/28/2015, and is a smart beta exchange traded fund that provides broad exposure to the Foreign Small/Mid Blend ETF

The iShares U.S. Healthcare Providers ETF (IHF) was launched on May 1, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Healthcare -

Launched on August 13, 2013, the Schwab Fundamental U.S. Large Company ETF (FNDX) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Value segment of

A smart beta exchange traded fund, the WisdomTree Europe Hedged Equity ETF (HEDJ) debuted on 01/04/2010, and offers broad exposure to the European Equity ETFs category of the market.

What Are Smart

Making its debut on 02/23/2007, smart beta exchange traded fund WisdomTree U.S. MidCap ETF (EZM) provides investors broad exposure to the Style Box - Mid Cap Value category of the market.

What Are

Launched on July 10, 2001, the iShares Semiconductor ETF (SOXX) is a passively managed exchange traded fund designed to provide a broad exposure to the Technology - Semiconductors segment of the

Looking for broad exposure to the Financials - Broad segment of the equity market? You should consider the iShares U.S. Financials ETF (IYF), a passively managed exchange traded fund launched on May

The FlexShares High Yield Value-Scored Bond ETF (HYGV) made its debut on 07/17/2018, and is a smart beta exchange traded fund that provides broad exposure to the High-Yield/Junk Bond ETFs category

Looking for broad exposure to the Large Cap Value segment of the US equity market? You should consider the Invesco S&P 500 Revenue ETF (RWL), a passively managed exchange traded fund launched on

The Schwab U.S. Mid-Cap ETF (SCHM) was launched on January 13, 2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Mid Cap Blend segment of the US equity

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: 

Alto Ingredients, Inc. ALTO: This specialty chemicals and renewable fuels company has seen the Zacks Consensus Estimate for

• Shares of Dominion Energy Inc. (D) tumbled 3.7% after the U.S. government halted one of its East Coast wind energy projects.
• Maplebear Inc.’s (CART) shares fell 2% following the company’s

U.S. stock markets closed higher on Monday to start the Christmas week. Wall Street generally remains positive in the last two truncated trading weeks of any year with muted volumes. This year

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: 

Alamo Group Inc. ALG is a specialty machinery company. The Zacks Consensus Estimate for its current year earnings has been

Here are three stocks with buy rank and strong income characteristics for investors to consider today, Dec. 23rd: 

Jackson Financial Inc. JXN: This financial services company has witnessed the Zacks

Acadia Healthcare Company Overview

Zacks Rank #5 (Strong Sell) stock Acadia Healthcare Company, Inc. (ACHC) is a behavioral healthcare provider. Headquartered in Franklin, TN, Acadia Healthcare owns

MDB Company Overview and Bull Case

Zacks Rank #1 (Strong Buy) stock MongoDB (MDB) is a leading database software company. Think of a traditional database (like a spreadsheet or filing cabinet) as

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, Dec. 23: 

Ciena Corporation CIEN: This network technology company carries a Zacks Rank #1, and

Johnson & Johnson JNJ announced that the FDA has approved the subcutaneous (under the skin or SC) formulation of its EGFR/MET inhibitor, Rybrevant (amivantamab). This version, which will be marketed

Here are three stocks with buy rank and strong value characteristics for investors to consider today, Dec. 23: 

Jackson Financial Inc. JXN: This financial services company carries a Zacks Rank #1

AstraZeneca PLC AZN and its Japan-based partner Daiichi Sankyo announced that the FDA has approved their blockbuster antibody-drug conjugate (ADC), Enhertu, for first-line use in breast cancer

In the latest close session, T. Rowe Price (TROW) was up +1.47% at $104.80. The stock outpaced the S&P 500's daily gain of 0.64%. Meanwhile, the Dow gained 0.47%, and the Nasdaq, a tech-heavy index